Evinature's Innovative CurQD Selected for Military-Funded Ulcerative Colitis Study Evinature's CurQD has been chosen for a pivotal U.S. Department of Defense clinical trial aimed at improving ulcerative colitis treatment through a combined approach.

Evinature's Innovative CurQD Selected for Military-Funded Ulcerative Colitis Study #USA #New_York #Ulcerative_Colitis #Evinature #CurQD